A method for accessing the formally 14 VE iridium(III) hydride fragment {Ir(IBioxMe 4 ) 2 
1 However, despite finding notable application in palladiumcatalysed cross-coupling reactions, the coordination chemistry of IBiox ligands has remained largely unexplored. With the aim of investigating low-coordinate NHC complexes of rhodium and iridium, we have recently begun to expand the coordination chemistry of IBiox ligands, seeking to exploit their conformational rigidity to avoid intramolecular cyclometalation reactions that can occur via C−H bond activation of the downward pointing alkyl and aryl NHC appendages. 2, 3 In particular, we have focused our efforts on IBioxMe 4 , which shares many structural similarities with the commonly employed I t Bu ligand that has been shown to undergo cyclometalation reactions when partnered with reactive late transition metal fragments (Scheme 1).
4,5
Chart 1: IBiox ligands developed by Glorius. 3 ] + B (COE = cyclooctene, Scheme 2). 6 The rigid geometry of IBioxMe 4 appears to prohibit the adoption of any significant agostic interactions and remarkably, despite the high degree of electronic unsaturation, the homoleptic complex displays complete solution stability (CD 2 Cl 2 or 1,2-difluorobenzene, 48 h at 293 K). Attempts to prepare analogous iridium complexes lead instead to intermolecular C-H bond activation of the fluoroarene solvents employed (i.e. C, D in Scheme 2). 7 Such reactivity is fully inline with the more energetically accessible higher oxidation states of the heavier group 9 congener and reinforces the ability to partner IBioxMe 4 with reactive metal centres without intramolecular activation. 8 Cyclometalation, double cyclometalation and dehydrogenation of the N-alkyl and aryl substituents of NHC ligands are otherwise well documented for iridium systems. Thermal ellipsoids for selected atoms are drawn at the 50% probability level; most hydrogen atoms (hydrides located in 4), anions and solvent (5) are omitted for clarity; only one of the two independent molecules shown for 5. Selected bond lengths (Å) and angles (º): 3 -Ir1-Cl2, 2.4499(13); Ir1A-Cl2, 2.4817(13); Ir1-C3, 2.047(4); Ir1-Cl8, 2.038(4); Ir1A-C3A, 2.038(4); Ir1A-C18A, 2.034(5); Ir1-Cl2-Ir1A, 171.47 (7); C3-Ir1-C18, 176.35 (18); C3A-Ir1A-C18A, 178.62 (19) ; All Θ NHC > 175; 4 -Ir1-H2 = Ir1-H3, 1.36 (2) were reacted with ethylene (1 atm) and COE (10 eqv (2); Ir1-Cnt(C6,C7), 2.047(2); Ir1-C10, 2.088(2); Ir1-C25, 2.084(2); C2-C3, 1.398(3); C6-C7, 1.395(3); Cnt(C2,C3)-Ir1-Cnt(C6,C7), 85.28(9); C10-Ir1-C25, 100.07 (8); Θ NHC (@C10), 167.6(3); Θ NHC (@C25), 176.9(3); 8 -Ir1-C2, 1.913(3); Ir1-C4, 1.899(3); Ir1-C6, 2.064(3); Ir1-C21, 2.064(2); C2-Ir1-C4, 170.13(14); C6-Ir1-C21, 177.15 (11); All Θ NHC > 175.
14 In order to further understand the structure of 6, a series of model conformational isomers bearing instead the less bulky IBioxH 4 ligand were optimised employing Density Functional Theory (DFT; BP86-D3/def2-TZVPP). These optimisations attempted to place the ethylene ligands in ideal orthogonal (6'), perpendicular (6a') or co-planar (6b') orientations - Figure 3 . In contrast to the distorted geometry observed experimentally for 6, the ethylene ligands in the optimised structure of 6' bind with ideal angles (0º, 90º) with respect to the coordination plane. The distorted geometry was also retained on optimisation of the full system (i.e. 6), suggesting the methyl substituents counteract adoption of an ideal orthogonal ethylene orientation (see Figure S14 ). Nevertheless, 6' was found to be the lowest energy model conformer.
Beginning the optimisation with the alkene ligands perpendicular to the NHC-M-NHC vector led to adoption of a complex with pseudo saw-horse geometry 6a', 12.1 kJ mol -1 higher in energy than 6', where the ethylene ligands are bowed away from linearity (Cnt(C=C)-Ir-Cnt(C=C') = 145º). Restraining the ethylene ligands in an alternative parallel alignment also led to departure from square planar geometry and is much more destabilising, with 6b' calculated to be 80.4 kJ mol -1 higher in energy than 6'. 21 The relative energies of these isomers lead us to hypothesise that the high symmetry of 6 observed in solution (200 -298 K) is a result of time-averaged fluxionality originating from facile and synchronized rotation of the ethylene ligands about the respective metal-ligand vectors -the high energy calculated for 6b' is incommensurate with independent rotation. Energy Decomposition Analysis (EDA-NOCV) of the isomers indicated that the perpendicular ethylene ligand in 6' shows a higher intrinsic bond strength than the co-planar ligand (ΔE int (C 2 H 4 ) = -261.5 (perpendicular), -238.0 kJ mol -1 (co-planar); Table S1 and Figure S15 ). This is consistent with the experimental metrics and inspection of the deformation densities from NOCV analysis for the binding of the ethylene ligands in 6' shows significantly larger absolute M→L and particularly L→M bonding interactions for the perpendicular ligand, summing up to an increased orbital interaction energy (ΔE orb = - (Table S1 ).
6' 6a'
6b' E rel = 0.0 kJ mol Figure 2 ). When the reaction was performed on a preparative scale, 7 was obtained in 68% isolated yield. Figure S13 ). Iridium complexes and in particular iridium pincer compounds are well documented to promote dehydrogenation reactions. 22, 23 was verified by independent synthesis from 1 (Scheme 4, Figure 2 ). For comparison, and as expected, alkene substitution was an order of magnitude more rapid in 6 (t 1/2 = 4 h).
Summary
Following on from previous work employing the tetra methyl 
Experimental

General experimental methods
All manipulations were performed under an atmosphere of argon, using Schlenk and glove box techniques. IBioxMe 4 (0.0023 g, 0.011 mmol) was added 1,2-C 6 H 4 F 2 (1 mL) under a H 2 atmosphere (1 atm). The solution was stirred at room temperature for 16 h, then freeze-pump-thaw degassed three times within 6 h and placed under argon. The solvent was removed under vacuum and the resulting the red solid extracted with dichloromethane (1 mL) to afford 5 after layering the solution with heptane (12 mL). Yield = 0.012 g (74%, red crystals). , 47.13; H, 3.57; N, 3.55. Found: C, 47.03; H, 3.46; N, 3.57 . i. To a mixture of 1 (0.0100 g, 0.013 mmol) and Na[BAr ii. To a mixture of 1 (0.0075 g, 0.010 mmol) and Na[BAr iii. To a mixture of 1 (0.0075 g, 0.010 mmol) and Na[BAr iv. To a mixture of 1 (0.0100 g, 0.0133 mmol) and Na[BAr Solutions of 3 and Na[BAr i. The mixture of 3 and Na [BAr F 4 ] in 1,2-C 6 H 4 F 2 prepared as described above was placed under argon and added to 2,2'-bipyridine (0.0023 g, 0.0146 mmol). Quantitative formation of 4 was observed by 1 H NMR spectroscopy within 15 min at 293 K.
H NMR
ii. ii. Solution stability was tested using a solution of isolated 3 (0.0105 g, 0.0050 mmol) in CD 2 Cl 2 (0.5 mL) in a J Young's valve NMR tube. Only minor decomposition (< 2%) was observed after 24 h at 293 K, by 1 H NMR spectroscopy.
iii. To a mixture of isolated 3 (0.007 g, 0.0033 mmol), Na[BAr i. Solution stability was tested using a solution of isolated 6 (0.0153 g, 0.010 mmol) in 1,2-C 6 H 4 F 2 (0.5 mL)
or CD 2 Cl 2 (0.5 mL) in a J Young's valve NMR tube. No significant change was observed after 24 h at 293 K, by 1 H NMR spectroscopy.
ii. A solution of isolated 6 (0.0153 g, 0.010 mmol) in 1,2-C 6 H 4 F 2 (0.5 mL) was placed under an atmosphere of CO (1 atm) in a J Young's valve NMR tube and the ensuing reaction was followed in situ by 1 H NMR spectroscopy. Complex 8 was formed quantitatively within 24 h at 293 K (t 1/2 = 4 h).
[Ir (IBioxMe 4 ) i. Solution stability was tested using a solution of isolated 7 (0.0158 g, 0.010 mmol) in 1,2-C 6 H 4 F 2 (0.5 mL)
or CD 2 Cl 2 (0.5 mL) in a J Young's valve NMR tube. No change was observed after 24 h at 293 K, by 1 H NMR spectroscopy.
ii. A solution of isolated 7 (0.0079 g, 0.0050 mmol) in 1,2-C 6 H 4 F 2 (0.5 mL) was placed under an atmosphere of CO (1 atm) in a J Young's valve NMR tube and the ensuing reaction was followed in situ by 1 H NMR spectroscopy. Complex 8 was formed quantitatively within 14 days at 293 K (t 1/2 = 77 h).
Computational details
Geometry optimisations without symmetry constraints (except for 6b', as indicated) 21 
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